Novartis continues its multi-year review with new plans to close its production facility in Wehr, Germany. Novartis said the measures…

You’re reading the web version of DC Diagnosis, STAT’s twice-weekly newsletter on health and medical politics and policy. Sign up…

Written by Ben Felder, Midwest Survey, Midwest Survey May 5, 2026 Last summer, 18 different pesticide compounds were detected in…

Kyverna Therapeutics is taking a historic first step in approving a CAR-T therapy for an autoimmune disease. And now we’re…

Recent research published in journals nature communications Our results suggest that a single high dose of psilocybin can cause lasting…